US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 789.120
  • +6.770+0.87%
Close Dec 13 16:00 ET
  • 788.000
  • -1.120-0.14%
Post 20:01 ET
749.12BMarket Cap85.31P/E (TTM)

Eli Lilly and Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
20.43%11.44B
35.98%11.3B
25.98%8.77B
19.56%34.12B
28.10%9.35B
36.84%9.5B
28.11%8.31B
-10.88%6.96B
0.79%28.54B
-8.73%7.3B
Operating revenue
20.43%11.44B
35.98%11.3B
25.98%8.77B
19.56%34.12B
28.10%9.35B
36.84%9.5B
28.11%8.31B
-10.88%6.96B
0.79%28.54B
-8.73%7.3B
Cost of revenue
16.70%2.17B
20.07%2.17B
2.88%1.67B
6.82%7.08B
15.50%1.79B
17.79%1.86B
26.35%1.81B
-21.50%1.63B
-9.34%6.63B
-24.49%1.55B
Gross profit
21.34%9.27B
40.40%9.13B
33.02%7.09B
23.41%27.04B
31.49%7.57B
42.44%7.64B
28.61%6.5B
-7.05%5.33B
4.31%21.91B
-3.29%5.75B
Operating expense
14.74%4.83B
13.15%4.71B
20.46%4.36B
22.60%16.25B
23.24%4.03B
23.29%4.21B
25.77%4.17B
17.69%3.62B
1.42%13.26B
-4.43%3.27B
Selling and administrative expenses
16.40%2.1B
10.67%2B
12.41%1.84B
14.40%6.94B
15.15%1.46B
11.75%1.8B
18.23%1.81B
11.53%1.63B
-1.21%6.07B
-16.39%1.27B
-General and administrative expense
16.40%2.1B
10.67%2B
12.41%1.84B
14.40%6.94B
15.15%1.46B
11.75%1.8B
18.23%1.81B
11.53%1.63B
-1.21%6.07B
-16.39%1.27B
Research and development costs
13.49%2.73B
15.05%2.71B
27.09%2.52B
29.52%9.31B
28.40%2.56B
33.62%2.41B
32.25%2.36B
23.29%1.99B
3.75%7.19B
5.14%2B
Operating profit
29.45%4.43B
88.95%4.42B
59.53%2.74B
24.66%10.79B
42.31%3.54B
76.08%3.43B
34.02%2.34B
-35.61%1.71B
9.08%8.65B
-1.76%2.49B
Net non-operating interest income expense
-91.41%-144.9M
-96.90%-146.3M
-95.04%-133.8M
-16.18%-312.3M
-60.17%-93.7M
-23.29%-75.7M
-4.65%-74.3M
11.94%-68.6M
14.50%-268.8M
20.95%-58.5M
Non-operating interest income
-2.25%47.8M
-18.91%37.3M
33.92%45.8M
176.43%173.6M
74.51%44.5M
143.28%48.9M
350.98%46M
388.57%34.2M
147.24%62.8M
244.59%25.5M
Non-operating interest expense
54.65%192.7M
52.62%183.6M
74.71%179.6M
46.53%485.9M
64.52%138.2M
52.88%124.6M
48.15%120.3M
21.08%102.8M
-2.41%331.6M
3.19%84M
Other net income (expense)
7.58%-2.7B
-330.94%-755M
43.61%-65.7M
-148.43%-3.92B
-181.87%-937.5M
-817.61%-2.92B
69.94%-175.2M
78.09%-116.5M
-7.86%-1.58B
46.19%-332.6M
Gain on sale of security
278.70%112.4M
-143.30%-157.9M
216.79%16M
95.08%-20.2M
-52.78%121.3M
48.99%-62.9M
45.42%-64.9M
96.78%-13.7M
-332.17%-410.7M
375.64%256.9M
Special income (charges)
2.26%-2.91B
-506.90%-589.3M
-5.24%-110.5M
-235.40%-3.87B
-148.13%-690.3M
-1,006.40%-2.98B
77.95%-97.1M
36.59%-105M
31.83%-1.15B
48.69%-278.2M
-Less：Restructuring and merger&acquisition
----
----
----
97.83%45.5M
----
----
----
----
76.92%23M
----
-Less:Impairment of capital assets
--81.6M
--435M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
-5.00%2.83B
58.91%154.3M
5.24%110.5M
318.25%3.8B
159.31%622.6M
4,667.79%2.98B
-77.95%97.1M
-36.59%105M
-33.94%908.5M
-45.15%240.1M
-Write off
----
----
----
-89.98%22.2M
----
----
----
----
-26.89%221.6M
----
Other non- operating income (expenses)
-18.11%94.5M
40.91%-7.8M
1,209.09%28.8M
-128.67%-32.7M
-18.37%-368.5M
56.58%115.4M
44.07%-13.2M
-96.29%2.2M
-127.82%-14.3M
-1,899.42%-311.3M
Income before tax
271.82%1.59B
68.38%3.52B
65.79%2.54B
-3.70%6.55B
19.67%2.51B
-72.71%427.2M
91.48%2.09B
-25.51%1.53B
10.57%6.81B
13.94%2.1B
Income tax
27.55%618.1M
68.93%550.2M
58.66%293.2M
134.01%1.31B
101.07%319.1M
325.83%484.6M
135.33%325.7M
22.63%184.8M
-2.13%561.6M
39.46%158.7M
Net income
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Net income continuous Operations
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Minority interest income
Net income attributable to the parent company
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Basic earnings per share
1,900.00%1.08
67.86%3.29
67.11%2.49
-16.02%5.82
19.38%2.4346
-103.73%-0.06
84.91%1.96
-29.38%1.49
12.68%6.93
12.67%2.0393
Diluted earnings per share
1,883.33%1.07
68.21%3.28
66.44%2.48
-15.94%5.8
18.67%2.42
-103.73%-0.06
85.71%1.95
-29.05%1.49
12.75%6.9
12.67%2.0393
Dividend per share
15.04%1.3
15.04%1.3
15.04%1.3
15.31%4.52
15.31%1.13
15.31%1.13
15.31%1.13
15.31%1.13
15.29%3.92
15.29%0.98
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 20.43%11.44B 35.98%11.3B 25.98%8.77B 19.56%34.12B 28.10%9.35B 36.84%9.5B 28.11%8.31B -10.88%6.96B 0.79%28.54B -8.73%7.3B
Operating revenue 20.43%11.44B 35.98%11.3B 25.98%8.77B 19.56%34.12B 28.10%9.35B 36.84%9.5B 28.11%8.31B -10.88%6.96B 0.79%28.54B -8.73%7.3B
Cost of revenue 16.70%2.17B 20.07%2.17B 2.88%1.67B 6.82%7.08B 15.50%1.79B 17.79%1.86B 26.35%1.81B -21.50%1.63B -9.34%6.63B -24.49%1.55B
Gross profit 21.34%9.27B 40.40%9.13B 33.02%7.09B 23.41%27.04B 31.49%7.57B 42.44%7.64B 28.61%6.5B -7.05%5.33B 4.31%21.91B -3.29%5.75B
Operating expense 14.74%4.83B 13.15%4.71B 20.46%4.36B 22.60%16.25B 23.24%4.03B 23.29%4.21B 25.77%4.17B 17.69%3.62B 1.42%13.26B -4.43%3.27B
Selling and administrative expenses 16.40%2.1B 10.67%2B 12.41%1.84B 14.40%6.94B 15.15%1.46B 11.75%1.8B 18.23%1.81B 11.53%1.63B -1.21%6.07B -16.39%1.27B
-General and administrative expense 16.40%2.1B 10.67%2B 12.41%1.84B 14.40%6.94B 15.15%1.46B 11.75%1.8B 18.23%1.81B 11.53%1.63B -1.21%6.07B -16.39%1.27B
Research and development costs 13.49%2.73B 15.05%2.71B 27.09%2.52B 29.52%9.31B 28.40%2.56B 33.62%2.41B 32.25%2.36B 23.29%1.99B 3.75%7.19B 5.14%2B
Operating profit 29.45%4.43B 88.95%4.42B 59.53%2.74B 24.66%10.79B 42.31%3.54B 76.08%3.43B 34.02%2.34B -35.61%1.71B 9.08%8.65B -1.76%2.49B
Net non-operating interest income expense -91.41%-144.9M -96.90%-146.3M -95.04%-133.8M -16.18%-312.3M -60.17%-93.7M -23.29%-75.7M -4.65%-74.3M 11.94%-68.6M 14.50%-268.8M 20.95%-58.5M
Non-operating interest income -2.25%47.8M -18.91%37.3M 33.92%45.8M 176.43%173.6M 74.51%44.5M 143.28%48.9M 350.98%46M 388.57%34.2M 147.24%62.8M 244.59%25.5M
Non-operating interest expense 54.65%192.7M 52.62%183.6M 74.71%179.6M 46.53%485.9M 64.52%138.2M 52.88%124.6M 48.15%120.3M 21.08%102.8M -2.41%331.6M 3.19%84M
Other net income (expense) 7.58%-2.7B -330.94%-755M 43.61%-65.7M -148.43%-3.92B -181.87%-937.5M -817.61%-2.92B 69.94%-175.2M 78.09%-116.5M -7.86%-1.58B 46.19%-332.6M
Gain on sale of security 278.70%112.4M -143.30%-157.9M 216.79%16M 95.08%-20.2M -52.78%121.3M 48.99%-62.9M 45.42%-64.9M 96.78%-13.7M -332.17%-410.7M 375.64%256.9M
Special income (charges) 2.26%-2.91B -506.90%-589.3M -5.24%-110.5M -235.40%-3.87B -148.13%-690.3M -1,006.40%-2.98B 77.95%-97.1M 36.59%-105M 31.83%-1.15B 48.69%-278.2M
-Less：Restructuring and merger&acquisition ---- ---- ---- 97.83%45.5M ---- ---- ---- ---- 76.92%23M ----
-Less:Impairment of capital assets --81.6M --435M ---- ---- ---- --0 --0 ---- ---- ----
-Less:Other special charges -5.00%2.83B 58.91%154.3M 5.24%110.5M 318.25%3.8B 159.31%622.6M 4,667.79%2.98B -77.95%97.1M -36.59%105M -33.94%908.5M -45.15%240.1M
-Write off ---- ---- ---- -89.98%22.2M ---- ---- ---- ---- -26.89%221.6M ----
Other non- operating income (expenses) -18.11%94.5M 40.91%-7.8M 1,209.09%28.8M -128.67%-32.7M -18.37%-368.5M 56.58%115.4M 44.07%-13.2M -96.29%2.2M -127.82%-14.3M -1,899.42%-311.3M
Income before tax 271.82%1.59B 68.38%3.52B 65.79%2.54B -3.70%6.55B 19.67%2.51B -72.71%427.2M 91.48%2.09B -25.51%1.53B 10.57%6.81B 13.94%2.1B
Income tax 27.55%618.1M 68.93%550.2M 58.66%293.2M 134.01%1.31B 101.07%319.1M 325.83%484.6M 135.33%325.7M 22.63%184.8M -2.13%561.6M 39.46%158.7M
Net income 1,790.42%970.3M 68.27%2.97B 66.77%2.24B -16.08%5.24B 13.01%2.19B -103.95%-57.4M 85.11%1.76B -29.32%1.34B 11.88%6.24B 12.26%1.94B
Net income continuous Operations 1,790.42%970.3M 68.27%2.97B 66.77%2.24B -16.08%5.24B 13.01%2.19B -103.95%-57.4M 85.11%1.76B -29.32%1.34B 11.88%6.24B 12.26%1.94B
Minority interest income
Net income attributable to the parent company 1,790.42%970.3M 68.27%2.97B 66.77%2.24B -16.08%5.24B 13.01%2.19B -103.95%-57.4M 85.11%1.76B -29.32%1.34B 11.88%6.24B 12.26%1.94B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1,790.42%970.3M 68.27%2.97B 66.77%2.24B -16.08%5.24B 13.01%2.19B -103.95%-57.4M 85.11%1.76B -29.32%1.34B 11.88%6.24B 12.26%1.94B
Basic earnings per share 1,900.00%1.08 67.86%3.29 67.11%2.49 -16.02%5.82 19.38%2.4346 -103.73%-0.06 84.91%1.96 -29.38%1.49 12.68%6.93 12.67%2.0393
Diluted earnings per share 1,883.33%1.07 68.21%3.28 66.44%2.48 -15.94%5.8 18.67%2.42 -103.73%-0.06 85.71%1.95 -29.05%1.49 12.75%6.9 12.67%2.0393
Dividend per share 15.04%1.3 15.04%1.3 15.04%1.3 15.31%4.52 15.31%1.13 15.31%1.13 15.31%1.13 15.31%1.13 15.29%3.92 15.29%0.98
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-0.11%